Monograph Details
|
|
Gastrointestinal Tract
> Digestive and biliary disorders
|
|
KUTRASE |
| Manufacturer |
|
Schwarz Pharma, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Digestive enzymes. |
| Generic Name |
|
Lipase 1200 Units, amylase 30000 Units, protease 30000 Units; caps. |
| Indications |
|
Symptomatic treatment of digestive dysfunction. |
| Children |
|
Not recommended. |
| Adults |
|
May be opened and sprinkled on food. 1 cap with meals or snacks. |
| Contraindications |
|
Glaucoma. GI or urinary tract obstruction. Paralytic ileus. Intestinal atony. Unstable cardiovascular status. Severe ulcerative colitis. Toxic megacolon. Myasthenia gravis. Acute pancreatic conditions. Pork allergy. |
| Precautions |
|
High environmental temperature. Diarrhea (may indicate obstruction). Autonomic neuropathy. Hyperthyroidism. Cardiovascular disease (esp. tachycardia). CHF. Arrhythmias. Hypertension. Renal disease. Hiatal hernia associated with reflux esophagitis. Avoid inhaling contents of caps. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Avoid concomitant antacids. |
| Adverse Reactions |
|
Drowsiness, dizziness, blurred vision, other anticholinergic effects, suppression of lactation, paradoxical excitement, diarrhea. |
| How Supplied |
|
Caps—100 |
|
|
|
|
